You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
公司問答丨翔宇醫療:“經顱磁AI導航定位系統”等AI中醫理療機器人產品將陸續推向市場
格隆匯8月8日丨有投資者在互動平台向翔宇醫療(688626.SH)提問:國家出台了一系列促進中醫藥傳承創新發展的政策,請問公司在中醫藥板塊有哪些前沿技術和業務佈局?翔宇醫療回覆:公司系國家中醫診療設備生產示範基地建設單位、有12款產品入圍國家中醫藥局《中醫診療設備提升、改造、開發項目》、26款產品入圍《中醫診療設備評估選型推薦品目》,曾參與科技部“中醫藥現代化研究”-“中風後主要功能障礙的中醫康復研究”等國家重點專項的研發工作。此外,公司還高度重視中醫板塊前沿技術的研發,目前公司研發的“AI中醫理療機器人項目”,將通過採用3D深度視覺相機重構人體模型,高精度識別人體骨骼及穴位分佈和突破機器視覺和機械臂協同關鍵技術,實現治療靶點的自動定位和實時追蹤,解放治療師的雙手;公司研發的“經顱磁AI導航定位系統”等AI中醫理療機器人產品也將陸續推向市場。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account